XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Accounting Policies [Abstract]          
Research and Development Expense $ 139,188 $ 122,883 $ 210,442 $ 278,309  
Deferred Revenue 140,000   $ 140,000  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount     612,810,663 603,690,191  
Depreciation $ 5,465 $ 5,015 $ 10,930 $ 10,030